Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: August 19, 2022

Investigational Drug Information for BIIB021

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the development status for investigational drug BIIB021?

BIIB021 is an investigational drug.

There have been 7 clinical trials for BIIB021. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1^st 2009.

The most common disease conditions in clinical trials are Neoplasms, Breast Neoplasms, and Leukemia, Lymphocytic, Chronic, B-Cell. The leading clinical trial sponsors are Biogen and [disabled in preview].

Summary for BIIB021

US Patents	0
International Patents	0
US Patent Applications	551
WIPO Patent Applications	327
Japanese Patent Applications	226
Clinical Trial Progress	Phase 2 (2009-11-01)
Vendors	91

Recent Clinical Trials for BIIB021

Title	Sponsor	Phase
Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding	Biogen	Phase 2
Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors	Biogen	Phase 1
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)	Biogen	Phase 2

See all BIIB021 clinical trials

Clinical Trial Summary for BIIB021

Top disease conditions for BIIB021

Top clinical trial sponsors for BIIB021

See all BIIB021 clinical trials

US Patents for BIIB021

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Mallinckrodt

Boehringer Ingelheim

Johnson and Johnson

Baxter

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.